An Open-Label, Single-Dose, Multicenter, Pharmacokinetic, Safety and Tolerability Study of Valaciclovir Oral Suspension in Infants and Children

Trial Profile

An Open-Label, Single-Dose, Multicenter, Pharmacokinetic, Safety and Tolerability Study of Valaciclovir Oral Suspension in Infants and Children

Completed
Phase of Trial: Phase I

Latest Information Update: 13 Sep 2017

At a glance

  • Drugs Valaciclovir (Primary)
  • Indications Herpes simplex virus infections
  • Focus Pharmacokinetics
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 24 Jan 2011 Additional locations (Argentina, Sweden) identified as reported by ClinicalTrials.gov.
    • 15 Oct 2008 Actual start date changed from Dec 2002 to Jan 2003 as reported by ClinicalTrials.gov.
    • 09 Jun 2008 Status changed from in progress to completed according to ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top